SEARCH:   Advanced

Receive this page by email each issue: [Sign up for eTOCs] Other Issues: October 1 1996; 88 (7)   [Index by Author]  [Cover Caption]        EDITORIALS        REVIEW ARTICLES        ARTICLES        CORRESPONDENCE        PHOTOGRAPHS        ERRATUM Find articles in this issue containing these words: [Search ALL Issues] To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link. EDITORIALS: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment] JV Melo Blood 1996 88: 2375-2384. [PDF]   REVIEW ARTICLES: Mycosis fungoides and Sezary syndrome [see comments] E Diamandidou, PR Cohen, and R Kurzrock Blood 1996 88: 2385-2409. [PDF]   ARTICLES: Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) [see comments] F Pane, F Frigeri, M Sindona, L Luciano, F Ferrara, R Cimino, G Meloni, G Saglio, F Salvatore, and B Rotoli Blood 1996 88: 2410-2414. [Abstract] [PDF]   P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation DA Guyer, KL Moore, EB Lynam, CM Schammel, S Rogelj, RP McEver, and LA Sklar Blood 1996 88: 2415-2421. [Abstract] [PDF]   A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages R Horie, K Ito, M Tatewaki, M Nagai, S Aizawa, M Higashihara, T Ishida, J Inoue, H Takizawa, and T Watanabe Blood 1996 88: 2422-2432. [Abstract] [PDF]   Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor JC Eikenboom, T Matsushita, PH Reitsma, EA Tuley, G Castaman, E Briet, and JE Sadler Blood 1996 88: 2433-2441. [Abstract] [PDF]   Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells A Chakraborty, SM White, TS Schaefer, ED Ball, KF Dyer, and DJ Tweardy Blood 1996 88: 2442-2449. [Abstract] [PDF]   Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells J Molldrem, S Dermime, K Parker, YZ Jiang, D Mavroudis, N Hensel, P Fukushima, and AJ Barrett Blood 1996 88: 2450-2457. [Abstract] [PDF]   Hematopoiesis in mice lacking the entire granulocyte-macrophage colony- stimulating factor/interleukin-3/interleukin-5 functions R Nishinakamura, A Miyajima, PJ Mee, VL Tybulewicz, and R Murray Blood 1996 88: 2458-2464. [Abstract] [PDF]   Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin HL 2nd Preas, D Reda, M Tropea, RW Vandivier, SM Banks, JM Agosti, and AF Suffredini Blood 1996 88: 2465-2472. [Abstract] [PDF]   Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia M Beran, H Kantarjian, S O'Brien, C Koller, M al-Bitar, S Arbuck, S Pierce, M Moore, JL Abbruzzese, M Andreeff, M Keating, and E Estey Blood 1996 88: 2473-2479. [Abstract] [PDF]   A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group E Wattel, A Guerci, B Hecquet, T Economopoulos, A Copplestone, B Mahe, ME Couteaux, L Resegotti, V Voglova, C Foussard, B Pegourie, JL Michaux, E Deconinck, AM Stoppa, G Mufti, D Oscier, and P Fenaux Blood 1996 88: 2480-2487. [Abstract] [PDF]   Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus E Morii, T Tsujimura, T Jippo, K Hashimoto, K Takebayashi, K Tsujino, S Nomura, M Yamamoto, and Y Kitamura Blood 1996 88: 2488-2494. [Abstract] [PDF]   Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice F Varas, A Bernad, and JA Bueren Blood 1996 88: 2495-2501. [Abstract] [PDF]   Estimation of the number of hematopoietic precursor cells during fetal mouse development by covariance analysis CN Berger and KS Sturm Blood 1996 88: 2502-2509. [Abstract] [PDF]   Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro M Holberg-Petersen, H Rollag, S Beck, I Overli, G Tjonnfjord, TG Abrahamsen, M Degre, and K Hestdal Blood 1996 88: 2510-2516. [Abstract] [PDF]   E3, a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha LM Scott, L Mueller, and SJ Collins Blood 1996 88: 2517-2530. [Abstract] [PDF]   Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures U Sarma and AM Flanagan Blood 1996 88: 2531-2540. [Abstract] [PDF]   In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC- positive Langerhans cell and the interdigitating dendritic cell type B Herbst, G Kohler, A Mackensen, H Veelken, P Kulmburg, FM Rosenthal, HE Schaefer, R Mertelsmann, P Fisch, and A Lindemann Blood 1996 88: 2541-2548. [Abstract] [PDF]   Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells RM Weber-Nordt, R Henschler, E Schott, J Wehinger, D Behringer, R Mertelsmann, and J Finke Blood 1996 88: 2549-2558. [Abstract] [PDF]   Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets DJ Mancuso, PA Kroner, PA Christopherson, EA Vokac, JC Gill, and RR Montgomery Blood 1996 88: 2559-2568. [Abstract] [PDF]   Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen S Godyna, M Diaz-Ricart, and WS Argraves Blood 1996 88: 2569-2577. [Abstract] [PDF]   Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis K Cohen-Solal, JL Villeval, M Titeux, S Lok, W Vainchenker, and F Wendling Blood 1996 88: 2578-2584. [Abstract] [PDF]   Biosynthesis of prothrombin: intracellular localization of the vitamin K-dependent carboxylase and the sites of gamma-carboxylation JA Bristol, JV Ratcliffe, DA Roth, MA Jacobs, BC Furie, and B Furie Blood 1996 88: 2585-2593. [Abstract] [PDF]   Affinity modulation of the platelet integrin alpha IIb beta 3 by alpha- chymotrypsin: a possible role for Na+/Ca2+ exchanger M Shiraga, Y Tomiyama, S Honda, H Kashiwagi, S Kosugi, M Handa, Y Ikeda, Y Kanakura, Y Kurata, and Y Matsuzawa Blood 1996 88: 2594-2602. [Abstract] [PDF]   Recombinant human factor IX: replacement therapy, prophylaxis, and pharmacokinetics in canine hemophilia B KM Brinkhous, JL Sigman, MS Read, PF Stewart, KP McCarthy, GA Timony, SD Leppanen, BJ Rup, JC Jr Keith, PD Garzone, and RG Schaub Blood 1996 88: 2603-2610. [Abstract] [PDF]   Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia AS O'Marcaigh, WL Nichols, NL Hassinger, JD Mullins, AA Mallouh, GS Gilchrist, and WG Owen Blood 1996 88: 2611-2618. [Abstract] [PDF]   Alloantigen presenting function of normal human CD34+ hematopoietic cells D Rondelli, RG Andrews, JA Hansen, R Ryncarz, MA Faerber, and C Anasetti Blood 1996 88: 2619-2675. [Abstract] [PDF]   Markedly disturbed glutathione redox status in CD45RA+CD4+ lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset P Aukrust, AM Svardal, F Muller, B Lunden, I Nordoy, and SS Froland Blood 1996 88: 2626-2633. [Abstract] [PDF]   Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony- stimulating factor analogue E21R PO Iversen, RL Rodwell, L Pitcher, KM Taylor, and AF Lopez Blood 1996 88: 2634-2639. [Abstract] [PDF]   Indication of an involvement of interleukin-1 beta converting enzyme- like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes SD Mundle, P Venugopal, JD Cartlidge, DV Pandav, L Broady-Robinson, S Gezer, EL Robin, SR Rifkin, M Klein, DE Alston, BM Hernandez, D Rosi, S Alvi, VT Shetty, SA Gregory, and A Raza Blood 1996 88: 2640-2647. [Abstract] [PDF]   Establishment and characterization of a primary effusion (body cavity- based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus L Arvanitakis, EA Mesri, RG Nador, JW Said, AS Asch, DM Knowles, and E Cesarman Blood 1996 88: 2648-2654. [Abstract] [PDF]   Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice T Lapidot, T Grunberger, J Vormoor, Z Estrov, O Kollet, N Bunin, R Zaizov, DE Williams, and MH Freedman Blood 1996 88: 2655-2664. [Abstract] [PDF]   Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval SK Horrigan, CA Westbrook, AH Kim, M Banerjee, W Stock, and RA Larson Blood 1996 88: 2665-2670. [Abstract] [PDF]   Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines A Rosenauer, JV Raelson, C Nervi, P Eydoux, A DeBlasio, and WH Jr Miller Blood 1996 88: 2671-2682. [Abstract] [PDF]   Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells N Iwata, T Murayama, Y Matsumori, M Ito, A Nagata, T Taniguchi, K Chihara, Y Matsuo, J Minowada, and T Matsui Blood 1996 88: 2683-2689. [Abstract] [PDF]   Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera FA Asimakopoulos, JG Gilbert, MA Aldred, TC Pearson, and AR Green Blood 1996 88: 2690-2698. [Abstract] [PDF]   Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial P Liu, T Leong, L Quam, D Billadeau, NE Kay, P Greipp, RA Kyle, MM Oken, and B Van Ness Blood 1996 88: 2699-2706. [Abstract] [PDF]   Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells W Vogel, D Behringer, S Scheding, L Kanz, and W Brugger Blood 1996 88: 2707-2713. [Abstract] [PDF]   Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex S Zhan, N Vazquez, S Zhan, FB Wientjes, ML Budarf, E Schrock, T Ried, ED Green, and SJ Chanock Blood 1996 88: 2714-2721. [Abstract] [PDF]   Targeted disruption of guanosine diphosphate-dissociation inhibitor for Rho-related proteins, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation JC Guillemot, BA Kruskal, CN Adra, S Zhu, JL Ko, P Burch, K Nocka, K Seetoo, E Simons, and B Lim Blood 1996 88: 2722-2731. [Abstract] [PDF]   Molecular genetic analysis of variant phenotypes of the ABO blood group system K Ogasawara, R Yabe, M Uchikawa, N Saitou, M Bannai, K Nakata, M Takenaka, K Fujisawa, Y Ishikawa, T Juji, and K Tokunaga Blood 1996 88: 2732-2737. [Abstract] [PDF]   Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse L De Franceschi, Y Beuzard, H Jouault, and C Brugnara Blood 1996 88: 2738-2744. [Abstract] [PDF]   Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage AC Rybicki, RS Schwartz, EJ Hustedt, and CE Cobb Blood 1996 88: 2745-2753. [Abstract] [PDF]   Receptor specificity of clinical Plasmodium falciparum isolates: nonadherence to cell-bound E-selectin and vascular cell adhesion molecule-1 R Udomsangpetch, BJ Taylor, S Looareesuwan, NJ White, JF Elliott, and M Ho Blood 1996 88: 2754-2760. [Abstract] [PDF]   Interaction of hemoglobin E and pyrimidine 5' nucleotidase deficiency DC Rees, J Duley, HA Simmonds, B Wonke, SL Thein, JB Clegg, and DJ Weatherall Blood 1996 88: 2761-2767. [Abstract] [PDF]   Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction L Muratori, D Gibellini, M Lenzi, M Cataleta, P Muratori, MC Morelli, and FB Bianchi Blood 1996 88: 2768-2774. [Abstract] [PDF]   Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow HD Ottinger, DW Beelen, B Scheulen, UW Schaefer, and H Grosse-Wilde Blood 1996 88: 2775-2779. [Abstract] [PDF]   High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission AS Freedman, JG Gribben, D Neuberg, P Mauch, RJ Soiffer, KC Anderson, L Pandite, MJ Robertson, M Kroon, J Ritz, and LM Nadler Blood 1996 88: 2780-2786. [Abstract] [PDF]   Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome WI Bensinger, CD Buckner, C Anasetti, R Clift, R Storb, T Barnett, T Chauncey, H Shulman, and FR Appelbaum Blood 1996 88: 2787-2793. [Abstract] [PDF]   Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation WI Bensinger, R Clift, P Martin, FR Appelbaum, T Demirer, T Gooley, K Lilleby, S Rowley, J Sanders, R Storb, and CD Buckner Blood 1996 88: 2794-2800. [Abstract] [PDF]   Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients RL Comenzo, E Vosburgh, RW Simms, P Bergethon, D Sarnacki, K Finn, S Dubrey, DV Faller, DG Wright, RH Falk, and M Skinner Blood 1996 88: 2801-2806. [Abstract] [PDF]   CORRESPONDENCE: Hydroxyurea therapy in highly unstable hemoglobin carriers [letter] C Rose, F Bauters, and F Galacteros Blood 1996 88: 2807-2808. [PDF]   Molecular investigation of secondary chronic myeloid leukemia [letter] RC Aguiar, H Sill, A Hochhaus, JM Goldman, and NC Cross Blood 1996 88: 2808-2809. [PDF]   PHOTOGRAPHS: A. M. Dvorak Blood 1996 88: 2530. [PDF]   ERRATUM: Erratum for vol. 87, p. 3694 Blood 1996 88: 2818. [PDF]   Erratum for vol. 87, p. 1985 Blood 1996 88: 2818. [PDF]   Erratum for vol. 87, p. 3135 Blood 1996 88: 2818. [PDF]   Erratum for vol. 88, p. 1614 Blood 1996 88: 2818. [PDF]   To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

	Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020